FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:329-333 January 29, 1998 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hellman, S. Related Article by Overgaard, M. Related Article by Ragaz, J.

To the Editor: The study by Overgaard et al. (Oct. 2 issue)¹ was designed to address the capacity of radiation therapy after mastectomy to reduce the frequency of distant relapse or to delay it significantly in women with stage I or II breast cancer, but the inclusion of patients with stage IIIA and stage IIIB disease creates interpretive difficulties. There are no data concerning the number and distribution of patients with tumor stage T4, nor is it clear how many patients with T3 disease were classified as having N0 (stage II) or N1 (stage III) nodal involvement. Table 1 of . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.